A new study raises the intriguing possibility that drugs prescribed to lower cholesterol may be effective against macular degeneration, a blinding eye disease.
Researchers at Washington University School of Medicine in St. Louis have found that age-related macular degeneration, the leading cause of vision loss in Americans over 50, shares a common link with atherosclerosis. Both problems have the same underlying defect: the inability to remove a buildup of fat and cholesterol.
The new study is published online in the journal Cell Metabolism.
Working in mice and in human cells, the researchers shed new light on how deposits of cholesterol contribute to macular degeneration and atherosclerosis and even blood vessel growth in some types of cancer.
Patients who have atherosclerosis often are prescribed medications to lower cholesterol and keep arteries clear. This study suggests that some of those same drugs could be evaluated in patients with macular degeneration.
“Based on our findings, we need to investigate whether vision loss caused by macular degeneration could be prevented with cholesterol-lowering eye drops or other medications that might prevent the buildup of lipids beneath the retina,” says senior investigator Rajendra S. Apte, MD, PhD.
The new research centers on macrophages, key immune cells that remove cholesterol and fats from tissues. In macular degeneration, the excessive buildup of cholesterol begins to occur as we age, and our macrophages begin to malfunction.
In the “dry” form of age-related macular degeneration, doctors examining the eye can see lipid deposits beneath the retina. As those deposits become larger and more numerous, they slowly begin to destroy the central part of the eye, interfering with the vision needed to read a book or drive a car.
As aging macrophages clear fewer fat deposits beneath the retina, the macrophage cells themselves can become bloated with cholesterol, creating an inflammatory process that leads to the formation of new blood vessels that can cause further damage. Those vessels characterize the later “wet” form of the disease.
“Ultimately, that inflammation creates a toxic mix of things that leads to new blood vessel growth,” Apte explains. “Most of the vision loss from ‘wet’ macular degeneration is the result of bleeding and scar-tissue formation related to abnormal vessel growth.”
The Latest Bing News on:
Atherosclerosis and macular degeneration
- Texas Company's Mission to Cure Macular Degeneration Blindnesson April 30, 2024 at 11:00 am
THE WOODLANDS, TX / ACCESSWIRE / April 30, 2024 / Mesogen Inc. out of The Woodlands, Texas, has developed a transplantable Retinal Pigmented ...
- Management of Choroidal Neovascularization in Myopic Macular Degenerationon April 28, 2024 at 5:00 pm
Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...
- Local group helps macular degeneration patients cope with vision losson April 26, 2024 at 3:07 am
To provide opportunity for encouragement, Phoenix-based Associated Retina Consultants, in coordination with the International Low Vision Support Group, has established a Macular Degeneration Support ...
- Top 6 Best Eye Supplement for Macular Degeneration in 2024on April 25, 2024 at 1:31 am
Macular degeneration is a prevalent eye disorder that typically results in loss of vision in individuals who are 50 years of age and older. Although there isn’t a recognized cure for this ...
- Dear Doctor: Can I use over-the-counter eye drops while on medications for macular degeneration?on April 24, 2024 at 11:00 pm
DEAR DR. ROACH: I am a healthy 67-year-old female being treated with Eylea for wet age-related macular degeneration (AMD). I have just had my second round of Eyelea, and with the pollen starting ...
- Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsighton April 22, 2024 at 1:31 pm
It has been reported that the prevalence of late-stage AMD increases with age. In Japan, it is observed that age-specific cases of geographic atrophy were most prevalent in the 85+ years age group, ...
- Nutrition for Healthy Eyes: What to Eat — and Avoid — if You Have Dry or Wet AMDon April 21, 2024 at 5:00 pm
Choose brightly colored fruits and dark, leafy vegetables such as kale, broccoli, and spinach, plus omega-3 packed nuts and fish, which slow the progress of age-related macular degeneration (AMD).
- Macular Degeneration vs. Glaucomaon April 18, 2024 at 5:00 pm
Both macular degeneration and glaucoma can lead to vision loss and blindness. But they have different causes and treatments. Age-related macular degeneration (AMD) and glaucoma are two of the most ...
- Neovascular Age-Related Macular Degenerationon April 17, 2024 at 5:00 pm
Choroidal neovascularization is the primary cause of visual loss in patients with age-related macular degeneration. Current treatments, proven to offer a benefit for these patients through ...
- Syfovre dosageon April 8, 2024 at 5:00 pm
Syfovre (pegcetacoplan) is a brand-name drug prescribed for an advanced form of macular degeneration in adults. Syfovre comes as an eye injection that’s given by an eye doctor once every 25–60 ...
The Latest Google Headlines on:
Atherosclerosis and macular degeneration
[google_news title=”” keyword=”atherosclerosis and macular degeneration” num_posts=”10″ blurb_length=”0″ show_thumb=”left”] [/vc_column_text]The Latest Bing News on:
Macrophages
- Study finds little gender difference in the perception of ambient room temperatureon May 1, 2024 at 6:40 am
A large team of medical researchers at the U.S. National Institutes of Health, has found very slight gender differences in temperature perception of a room at ambient conditions and very few gender ...
- Why Coya Therapeutics Is A Smart Speculative Buy For Neurodegenerative Diseaseson May 1, 2024 at 3:45 am
Coya Therapeutics is a biotech company developing therapies for neurodegenerative diseases. Read why I deem COYA stock as a good speculative buy.
- Study flags unexpected cells in lung as suspected source of severe COVIDon April 29, 2024 at 5:57 pm
A previously overlooked type of immune cell allows SARS-CoV-2 to proliferate, scientists have found. The discovery has important implications for preventing severe COVID-19.
- TNXP: Approval of First New Fibromyalgia Drug in 15 Years Possible in 2025…on April 29, 2024 at 8:31 am
TNXP READ THE FULL TNXP RESEARCH REPORT Business Update NDA Filing in 2H24; Pre-NDA Meeting in 2Q24 In the second half of 2024, Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) will be filing a new ...
- Ceapro Inc. Reports 2023 Financial Results and Operational Highlightson April 29, 2024 at 6:22 am
Ceapro’s achievement of key milestones and progress toward its next phase of growth– R&D activities focused on advancement ...
- Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Eventson April 29, 2024 at 5:43 am
Sepsis is a life-threatening disease with no therapies approved by the U.S. Food and Drug Administration (“FDA”) and a high unmet medical need. According to the U.S. Centers for Disease Control and ...
- 5 Mid-Stage ALS Drugs to Watchon April 28, 2024 at 9:14 pm
As the Phase III amyotrophic lateral sclerosis pipeline thins out, the ALS community is placing its hopes on earlier-stage trials sponsored by Denali Therapeutics, PTC Therapeutics and more.
- The Role of Resident Macrophages in Protecting the Liveron April 25, 2024 at 5:00 pm
Their findings are illustrated in Figure 1. Dr. Miyamoto, a lead author of the study, explained, “Our technology showed that these ‘sentinel macrophages’ play a crucial role in protecting the liver ...
- Identifying a new liver defender: The role of resident macrophageson April 25, 2024 at 7:30 am
Osaka University researchers have discovered liver resident macrophages' pivotal role in defending against gut bacteria and related substances entering via the portal vein, particularly under ...
- Can Your Immune System Be Rejuvenated? Yes, Says New Researchon April 19, 2024 at 11:01 am
As we age, the immune system begins to weaken. This leaves us exposed to dangerous infections. But a new study offers hope: we may soon be able to reverse the trend.
The Latest Google Headlines on:
Macrophages
[google_news title=”” keyword=”macrophages ” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]